Safety Study of F2695 SR in Major Depressive Disorder
NCT01034267
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
828
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
F2695 SR
Sponsor
Forest Laboratories